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enoxamine for hemodynamic support, raised ejection
fraction, diminished troponin release (a myocardial
marker of cellular injury), less ventricular fibrillation
after aortic unclamping (presumably from improved
excitation/contraction coupling), and, finally, shorter
intensive care unit stay (48 vs 60 hours), even though
the last variant is not significant due to increased vul-
nerability. These aforementioned “soft or surrogate”
end points conform precisely to their referenced
reports of benefits of leukocyte depletion in damaged
hearts. Conversely, no benefit of leukocyte depletion
has been established in patients with an ejection frac-
tion of more than 40%.
The merits of cardiac versus systemic leukocyte
depletion are clear, since systemic doses allowed only
38% reduction at the time of aortic unclamping. The
white cell filter becomes less functional after more than
1000 mL blood delivery, so that selection of one versus
two white blood filters becomes dependent on defining
the role of leukocyte depletion throughout all periods of
cold blood cardioplegia during aortic clamping, and/or
only in the warm 500- to 700-mL reperfusate.
Surgical reperfusion strategies become confusing to
our basic science and cardiology colleagues, who
address single events after short ischemic intervals,
whereas we confront prolonged ischemia for surgical
repair. Unidimensional focus on one element will not
be successful because ischemia unmasks many
changes. Our study, quoted in the reference list,2
showed that white blood cell depletion alone reduced
reperfusion injury but failed to restore contractility
unless leukocyte depletion supplemented a more
complex cardioplegic approach. The composite
approach is clear from this study, since their blood
cardioplegic solutions contain potassium, glucose,
citrate, and a buffer with good clinical results, even
without white blood cell depletion.1
We must establish cardiac surgical recognition of
global endothelial stunning and develop efforts to
reduce this injury during myocardial protection. In
damaged hearts, conventional cardioplegic solutions
can completely prevent myocyte injury, yet allow
endothelial damage with resultant white blood cell
adherence.3 A principal underlying mechanism is
endothelial loss of nitric oxide production, subse-
quently allowing the neutrophil and platelet adherence
Until recently, myocyte stunning from inadequate car-diac protection has been the main focus of interest
and is most relevant in damaged hearts (ie, hypertrophy,
unstable angina, and reduced ejection fraction) in which
vulnerability is accentuated. This injury is transient,
since stunning recovers after brief inotropic or mechan-
ical support. This editorial focuses on an expanding
recognition that both the myocyte and the endothelium
can be injured or stunned, as the two limbs are interre-
lated.
Damaged hearts exhibit loss of endothelium-depen-
dent factors and reduced nitric oxide formation. The
result is perioperative vasospasm, adherence of
platelets, and leukocyte attachment that also causes
capillary obstruction with inhomogeneous flow. The
essential theme is that the endothelium is injured,
because neutrophils do not attach, then roll, and finally
have parenchymal influence for oxygen radical injury
without such damage. This clinical report is the appli-
cation of an experimentally proven method to reduce
the consequences of endothelial damage.
The transient nature of stunning is clear. Brief leuko-
cyte depletion (ie, > 95% white blood cell reduction in
this study) is quickly reversed by blood with a normal
white cell count. However, the persistence of function-
al benefits indicates that residual protection is retained,
including experimental markers of reduced endothelial
adherence of white cells.
The expertise of Dr Roth’s surgical team1 is appar-
ent, with no intra-aortic balloon counterpulsations or
deaths in high-risk patients. Their carefully defined
data characterize the advantages of white blood cell
reduction in patients with ejection fractions of about
20%, through reduced needs for dopamine, absent
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and changing vasoactivity to impair subsequent
vasodilatation. White blood cell adhesion is only one
step in this injury.
Our principal surgical dilemma relates both to deal-
ing with global stunning and understanding why this
occurs. The neutrophil filter addresses the lesions
after they are present, with acceptance that brief
reperfusion interventions can reduce endothelial
injury. Studies that focus on maintaining the intrinsic
endothelium-dependent protective component, nitric
oxide generation, may be useful. Hiramatsu,4
Mizuno,3 Kronon,5 and their colleagues, discovered
that delivery of the natural nitric oxide precursor, L-
arginine, limits endothelial and myocyte damage,
even without white blood cell depletion.
Consequently, leukocyte depletion adds to the
expanding catalog of strategies for surgical correc-
tion, but efforts at preventing endothelial stunning,
rather than treating the injury, must be considered in
the future.
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